Want to join the conversation?
$BAX 2Q15 Call: The Gambro integration program continues to advance, we are on track to capture $100MM of cost synergies in 2015. And as we exit the year we’ll have successfully achieved 2/3 of our $300MM 2017 cost synergy target. We are executing on key opportunities to reduce structural cost and increase efficiencies across the global enterprise.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?